HIV Ag/Ab Combo Test in Kathmandu The 4th-generation screening standard explained

Overview of the HIV Ag/Ab Combination Test

The HIV Ag/Ab combination test — also called the 4th-generation test — is the current standard for HIV screening worldwide. It detects two different markers in a single blood sample: the p24 antigen, which is a viral protein that appears early in infection, and HIV antibodies, which the immune system produces later. This dual detection dramatically shortens the window period compared with older antibody-only tests.

The test replaced earlier generations for good reason. First- and second-generation tests detected only antibodies and required up to three months for reliable detection. Third-generation tests improved antibody sensitivity. The 4th-generation assay detects both antigen and antibody, reducing the window period to roughly two to six weeks depending on the platform — meaning earlier diagnosis and earlier treatment for people who test positive.

Understanding what the Ag/Ab test actually measures helps interpret results correctly. A negative result means neither antigen nor antibodies were detected at the time of testing — reliable if enough time has passed since exposure. A reactive result means one or both markers were detected and requires confirmatory testing before a diagnosis is made. The test does not measure viral load or immune status.

This page explains the technology, window periods, interpretation, costs in Kathmandu and how the Ag/Ab test fits into the broader HIV testing and treatment pathway.

What the Ag/Ab Test Actually Detects

The HIV Ag/Ab test detects two markers in a single blood sample. The p24 antigen is a protein from the viral core that appears in the blood roughly two weeks after infection — before the immune system has produced enough antibodies to detect. HIV antibodies are proteins the immune system makes in response to infection, which appear later but persist for life.

By detecting both markers simultaneously, the test catches infection earlier than antibody-only tests. If antigen is detected but antibodies are not yet present, the result is still reactive — the infection is there even though the immune response has not fully developed. This is why the 4th-generation test is the screening standard recommended by WHO and CDC.

• Detects p24 antigen — viral protein that appears ~2 weeks after infection.
• Detects HIV-1 and HIV-2 antibodies — immune response markers.
• Antigen detection shortens the window period significantly.
• Both markers can be detected in a single blood sample.
• A reactive result requires confirmatory testing before diagnosis.

Window Period and When to Test

The window period is the time between HIV infection and when a test can reliably detect it. For 4th-generation Ag/Ab assays, this is typically two to six weeks depending on the specific platform and individual immune response. This is significantly shorter than the three months required for reliable detection with older antibody-only tests.

However, no test can detect infection before the window period closes. Testing at day 7 after exposure will almost certainly be negative even if infected. For recent exposures, the safest approach is baseline testing now plus a repeat test after the window period — for example, at four weeks and again at twelve weeks to cover all scenarios.

• 4th-generation window period: approximately two to six weeks.
• Testing before the window closes can produce false negatives.
• Baseline + repeat testing is safest for recent exposures.
• A test at 4 weeks and repeat at 12 weeks covers virtually all scenarios.
• PEP within 72 hours is separate from testing — it prevents infection.

Interpreting Ag/Ab Test Results

A negative (non-reactive) Ag/Ab result means neither p24 antigen nor HIV antibodies were detected. If sufficient time has passed since exposure — at least four to six weeks for most people — this is reliable evidence of no HIV infection. For very recent exposures, a negative result is inconclusive and repeat testing is needed.

A reactive result means one or both markers were detected. This is NOT a diagnosis — it triggers confirmatory testing with a different method, such as HIV RNA PCR or a different antibody assay. Only after confirmation is a diagnosis made and treatment started. This two-step process prevents false-positive diagnoses.

• Negative result = no markers detected — reliable if window period has passed.
• Reactive result = markers detected — requires confirmatory testing.
• A reactive screen is never a diagnosis on its own.
• Confirmatory testing uses a different method to rule out false positives.
• Only confirmed diagnosis leads to treatment and counselling.

The Testing Process in Kathmandu

The Ag/Ab test requires a venous blood sample — a standard blood draw from the arm, not a finger prick. The sample goes to the laboratory where it is analyzed on an automated immunoassay platform. Results are typically available within one to two working days for laboratory testing, or within minutes for rapid point-of-care versions of similar technology.

At Thamel Clinic, the process starts with a confidential pre-test discussion about your exposure history and timing. The blood draw takes a few minutes. Results are delivered privately with a clinician available to explain what they mean and what happens next — whether that is reassurance, repeat testing or linkage to care.

• Venous blood draw required — not a finger-prick test.
• Laboratory processing on automated immunoassay platforms.
• Results typically within one to two working days.
• Pre-test counselling ensures the right timing and test.
• Post-test counselling explains results and next steps.

HIV Ag/Ab Testing Services and Pricing

Prices are indicative and confirmed at booking. Government programmes may offer free testing for eligible patients.

Related Services & Guides